These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5115670)

  • 21. [Immunity status of the Milanese population towards B-Hong Kong-8-73, the new B type strain and study of the immunizing activity of the old composition vaccine].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(5):429-35. PubMed ID: 4788200
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE IMPORTANCE OF ANTIGEN SELECTION (ALLANTOIS LETHAL ANTIGEN) AND THE TEST METHOD (DIRECT MOUSE IMMUNITY TEST) FOR STUDIES ON INFLUENZA IMMUNITY].
    HERZBERG K; REUSS K; DAHN R
    Z Hyg Infektionskr; 1964 Apr; 149():497-524. PubMed ID: 14214976
    [No Abstract]   [Full Text] [Related]  

  • 24. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract]   [Full Text] [Related]  

  • 26. Reactions of antibodies with surface antigens of influenza virus.
    Webster RG; Laver WG; Kilbourne ED
    J Gen Virol; 1968 Dec; 3(3):315-26. PubMed ID: 5711432
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody against influenza A2 virus neuraminidase in human sera.
    Schild GC
    J Hyg (Lond); 1969 Jun; 67(2):353-65. PubMed ID: 5256462
    [No Abstract]   [Full Text] [Related]  

  • 28. Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man.
    Bachmayer H; Liehl E; Schmidt G
    Dev Biol Stand; 1975; 28():336-9. PubMed ID: 1126577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antigenic characterization of hemagglutinin and neuraminidase in strains of influenza B virus isolated in Italy in the years 1962, 1967 and 1971].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1974; 53(2):342-50. PubMed ID: 4425573
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of neuraminidase antibody on Hong Kong influenza.
    Monto AS; Kendal AP
    Lancet; 1973 Mar; 1(7804):623-5. PubMed ID: 4121842
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E; Mauler R
    Dev Biol Stand; 1975; 28():319-23. PubMed ID: 1126575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
    Ogra PL; Chow T; Beutner KR; Rubi E; Strussenberg J; DeMello S; Rizzone C
    J Infect Dis; 1977 Apr; 135(4):499-506. PubMed ID: 856917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative studies of influenza virus strains isolated in Poland in 1967].
    Zgorzelska K
    Med Dosw Mikrobiol; 1969; 21(2):167-73. PubMed ID: 5348188
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombination of influenza A viruses of human and animal origin.
    Kolbourne ED
    Science; 1968 Apr; 160(3823):74-6. PubMed ID: 5642310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 40. Influenza virus titration, antigenic characterization, and serological methods for antibody detection.
    Klimov A; Balish A; Veguilla V; Sun H; Schiffer J; Lu X; Katz JM; Hancock K
    Methods Mol Biol; 2012; 865():25-51. PubMed ID: 22528152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.